Los Angeles-based Cedars-Sinai is participating in the National Cancer Institute's first long-term national study of cancer among Asian Americans. Led by the University of California San Francisco, the study aims to learn why Asian Americans experience higher rates of cancer…
The Latest
Advancements in immunotherapy and personalized medicine have pushed the oncology field forward, according to leaders from MD Anderson and City of Hope who shared their insights with Becker's.
Iowa City-based University of Iowa Health Care and Mission Cancer + Blood plan to partner in a $280 million deal to create a comprehensive cancer care network.
The U.S. spent $99 billion on both oral and clinician-administered cancer therapies in 2023, according to a report published in April by analytics firm IQVIA. As cancer drug prices continue to increase, spending is projected to grow.
Daniel Nikcevich, MD, saw a boat heading straight for him during a fishing trip in rural Minnesota.
Rochester, Minn.-based Mayo Clinic has broken ground on a $9 million cancer center expansion at its New Prague, Minn., medical campus.
Along with the premarket approval of Siemens' 3D breast-imaging technology, the FDA approved seven oncology and hematology drugs in September.
Six U.S. health systems and cancer centers have joined the recently launched Together for Supportive Cancer Care consortium alongside more than 30 research institutions and advocacy groups with the aim to make supportive cancer care the standard of care.
Michel Sadelain, MD, PhD, a CAR-T therapy innovator and one of the world's top immunologists, has left New York City-based Memorial Sloan Kettering Cancer Center for two new roles at Columbia University Irving Medical Center, also in New York City.
From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society.